Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-102248
Filing Date
2023-04-14
Accepted
2023-04-14 17:05:52
Documents
5
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 PRE 14A d439021dpre14a.htm PRE 14A 519620
2 GRAPHIC g439021g02.jpg GRAPHIC 284849
3 GRAPHIC g439021g03.jpg GRAPHIC 299817
4 GRAPHIC g439021g17d94.jpg GRAPHIC 78339
5 GRAPHIC g439021g46x63.jpg GRAPHIC 654046
  Complete submission text file 0001193125-23-102248.txt   2317796
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33038 | Film No.: 23821947
SIC: 2834 Pharmaceutical Preparations